Log in to your Inderes Free account to see all free content on this page.
NextCell Pharma
1.28 SEK
-5.74 %
Less than 1K followers
NXTCL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for NextCell Pharma
| Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.6 | 10.7 | 2.8 | 3.3 | 2.3 | 2.6 | 10.9 | 1.8 |
| EBITDA | -13.0 | -42.2 | -7.6 | -7.8 | -9.7 | -8.2 | -33.4 | -13.3 |
| EBIT | -13.6 | -43.2 | -8.3 | -8.5 | -10.4 | -8.8 | -35.9 | -13.9 |
| EBIT-% | -829.9 % | -405.0 % | -292.6 % | -260.3 % | -458.0 % | -338.2 % | -328.0 % | -785.4 % |
| Profit before taxes | -13.3 | -42.0 | -8.0 | -8.2 | -10.3 | -8.6 | -35.1 | -13.8 |
| Net income | -13.3 | -42.0 | -8.0 | -8.2 | -10.3 | -8.6 | -35.1 | -13.8 |
Login required
This content is only available for logged in users